as
TEST BANK FOR PHARMACOTHERAPEUTICS FOR as as
as
as
ADVANCED PRACTICE A PRACTICAL APPROACH 5TH
as as as as as as
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
as as as as as
PETERSON; VERONICA WILBUR; JENNIFER A.
as as as as as
REINHOLD
as
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
as as as as as as as as as
VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
as as as as as as as
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
as a s as a s as a s
, Tableofcontent as as
Chapter I Issues for the Practitioner in Drug Therapy
as as as as as as as as
Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
as as as as as as as as
Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics
as as a s as as as a s as as a s as
Chapter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and
as as as as as as as as as
Lactation Chapter 5 Pharmacotherapy Principles in Older Adults
as as as as as as as as
Chapter 6 Principles of Antimicrobial Therapy
as as as as as
Chapter 7 Pharmacogenomies
as as as
Chapter 8 The Economics of Pharmacotherapeutics
as as as as as
Chapter 9 Pharmacotherapy of Pain Management
as as as as as as
Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients
as as as as as as as as as
Chapter 11 Cannabis and Pain Management
as as as as as as
Chapter 12 Contact Dermatitis
as as as
Chapter 13 Fungal, Viral, and Bacterial Infections of the Skin
as as as as as as as as as
Chapter 14 Psoriasis
as as as
Chapter I5 Acne Vulgaris and Rosacea
as as as as as
Chapter 16 Ophthalmic Disorders
as as as as
Chapter I7 Otitis Media and Otitis Externa
as as as as as as
Chapter I8 Hypertension
as as as
Chapter I9 Hyperlipidemia
as as
Chapter 20 Chronic Stable Angina and Myocardial Infarction
as as as as as as as
Chapter 2I Heart Failure
as as as as
Chapter 22 Arrhythmias
as as
Chapter 23 Respiratory Infections
as as as
Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease
as as as as as as as
Chapter 25 Gastric, Functional, and Inflammatory Bowel Disorders
as as as as as as as as
Chapter 26 Gastroesophageal Reflux Disease and Peptic Ulcer Disease
as as as as as as as as as
Chapter 27 Liver Diseases
as as as as
Chapter 28 Urinary Tract Infection
as as as as
Chapter 29 Prostatic Disorders and Erectile Dysfunction
as as as as as as
Chapter 30 Overactive Bladder
as as as as
Chapter 3I Sexually Transmitted Infections
as as as as
Chapter 32 Osteoarthritis and Gout
as as as as as
Chapter 33 Osteoporosis
as as as
Chapter 34 Rheumatoid Arthritis
as as as
Chapter 35 Headaches
as as as
Chapter 36 Seizure Disorders
as as as
Chapter 37 Alzheimer's Disease
as as as as
Chapter 38 Parkinson's
a s as as
Disease
as
Chapter 39 Major Depressive Disorder and Bipolar Disorders
as as as as as as as
Chapter 40 Anxiety Disorders
as as as as
Chapter 41 Sleep Disorders
a s a s a s
Chapter 42 Attention Deficit Hyperactivity Disorder
as as as as as
Chapter 43 Substance Use Disorders
as as as as as
Chapter 44 Diabetes Mellitus
as as as
Chapter 45 Thyroid and Parathyroid Disorders
as as as as as
,Chapter 46 Allergies and Allergic Reactions
as as as as as
Chapter 47 Human Immunodeficiency
as as as as
Virus Chapter 48 Organ Transplantation
as as as as as
Chapter 49 Thromboembolic Disorders
as as as
Chapter 50 Anemias
as as as
Chapter 5l Immunizations
as as
Chapter 52 Smoking Cessation
as as as as
Chapter 53 Weight Loss
as as as as
Chapter 54 Contraception
as as as
Chapter 55 Menopause
as as
Chapter 56 Vaginitis
as as
, lOMoAR
as cPSD|
as 21007614
lOMoAR as cPSD| as 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
as as as as as as as as
MULTIPLE CHOICE as
1. Nurse practitioner prescriptive authority is regulated by:
as as as as as as
A. The National Council of State Boards of Nursing
as as as as as as as
B. The U.S. Drug Enforcement Administration
as as as as
C. The State Board of Nursing for each state
as as as as as as as
D. The State Board of Pharmacy
as as as as
ANS: a s C PTS: a s 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
as as as as as as as
A. The National Council of State Boards of Nursing
as as as as as as as
B. The U.S. Drug Enforcement Administration
as as as as
C. The State Board of Nursing
as as as as
D. The State Board of Medical Examiners
as as as as as
ANS: a s D PTS: a s 1
3. Clinical judgment in prescribing includes:
as as as as
A. Factoring in the cost to the patient of the medication prescribed
as as as as as as as as as as
B. Always prescribing the newest medication available for the disease process
as as as as as as as as as
C. Handing out drug samples to poor patients
as as as as as as
D. Prescribing all generic medications to cut costs as as as as as as
ANS: a s A PTS: a s 1
4. Criteria for choosing an effective drug for a disorder include:
as as as as as as as as as
A. Asking the patient what drug they think would work best for them
as as as as as as as as as as as
B. Consulting nationally recognized guidelines for disease management
as as as as as as
C. Prescribing medications that are available as samples before writing a prescription
as as as as as as as as as as
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
as as as as as as as
as prescribing
ANS: a s B PTS: a s 1
5. Nurse practitioner practice may thrive under health-care reform due to:
as as as as as as as as as
A. The demonstrated ability of nurse practitioners to control costs and improve
as as as as as as as as as as
patient outcomes
as as
B. The fact that nurse practitioners will be able to practice independently
as as as as as as as as as as
C. The fact that nurse practitioners will have full reimbursement under health-
as as as as as as as as as as
care reform as
D. The ability to shift accountability for Medicaid to the state level
as as as as as as as as as as
ANS: a s A PTS: a s 1